310 related articles for article (PubMed ID: 20404539)
21. In silico selection of therapeutic antibodies for development: viscosity, clearance, and chemical stability.
Sharma VK; Patapoff TW; Kabakoff B; Pai S; Hilario E; Zhang B; Li C; Borisov O; Kelley RF; Chorny I; Zhou JZ; Dill KA; Swartz TE
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18601-6. PubMed ID: 25512516
[TBL] [Abstract][Full Text] [Related]
22. Defining the right diluent for intravenous infusion of therapeutic antibodies.
Luo S; McSweeney KM; Wang T; Bacot SM; Feldman GM; Zhang B
MAbs; 2020; 12(1):1685814. PubMed ID: 31774346
[TBL] [Abstract][Full Text] [Related]
23. Development of two murine monoclonal antibodies recognizing human nG1m(a)-like isoallotypic markers.
Hajighasemi F; Khoshnoodi J; Shokri F
Hybridoma (Larchmt); 2008 Dec; 27(6):473-9. PubMed ID: 19108620
[TBL] [Abstract][Full Text] [Related]
24. Analysis of murine IgG isotype galactosylation in collagen-induced arthritis.
Williams PJ; Rademacher TW
Scand J Immunol; 1996 Oct; 44(4):381-7. PubMed ID: 8845032
[TBL] [Abstract][Full Text] [Related]
25. Human IgG subclass cross-species reactivity to mouse and cynomolgus monkey Fcγ receptors.
Derebe MG; Nanjunda RK; Gilliland GL; Lacy ER; Chiu ML
Immunol Lett; 2018 May; 197():1-8. PubMed ID: 29476755
[TBL] [Abstract][Full Text] [Related]
26. Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine.
Vermont CL; van Dijken HH; van Limpt CJ; de Groot R; van Alphen L; van Den Dobbelsteen GP
Infect Immun; 2002 Feb; 70(2):584-90. PubMed ID: 11796586
[TBL] [Abstract][Full Text] [Related]
27. Engineering an IgG Scaffold Lacking Effector Function with Optimized Developability.
Jacobsen FW; Stevenson R; Li C; Salimi-Moosavi H; Liu L; Wen J; Luo Q; Daris K; Buck L; Miller S; Ho SY; Wang W; Chen Q; Walker K; Wypych J; Narhi L; Gunasekaran K
J Biol Chem; 2017 Feb; 292(5):1865-1875. PubMed ID: 27994062
[TBL] [Abstract][Full Text] [Related]
28. Humanized IgG1 and IgG4 anti-CD4 monoclonal antibodies: effects on lymphocytes in the blood, lymph nodes, and renal allografts in cynomolgus monkeys.
Mourad GJ; Preffer FI; Wee SL; Powelson JA; Kawai T; Delmonico FL; Knowles RW; Cosimi AB; Colvin RB
Transplantation; 1998 Mar; 65(5):632-41. PubMed ID: 9521196
[TBL] [Abstract][Full Text] [Related]
29. Effects of genetic engineering on the pharmacokinetics of antibodies.
Colcher D; Goel A; Pavlinkova G; Beresford G; Booth B; Batra SK
Q J Nucl Med; 1999 Jun; 43(2):132-9. PubMed ID: 10429508
[TBL] [Abstract][Full Text] [Related]
30. Interaction sites on human IgG-Fc for FcgammaR: current models.
Jefferis R; Lund J
Immunol Lett; 2002 Jun; 82(1-2):57-65. PubMed ID: 12008035
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of serum IgG subclass deficiencies in B chronic lymphocytic leukemia.
Lacombe C; Gombert J; Dreyfus B; Brizard A; Preud'Homme JL
Clin Immunol; 1999 Jan; 90(1):128-32. PubMed ID: 9884361
[TBL] [Abstract][Full Text] [Related]
32. IgG isotype-specific auto-antibodies bind preferentially to cross-linked membrane Ig.
Fazekas G; Pálfi G; Wolff-Winiski B; Rosenwirth B; Dukor P; Gergely J; Rajnavölgyi E
Int Immunol; 1995 Jul; 7(7):1125-34. PubMed ID: 8527410
[TBL] [Abstract][Full Text] [Related]
33. The isotype repertoire of antibodies against novel UH-RA peptides in rheumatoid arthritis.
De Winter LM; Geusens P; Lenaerts J; Vanhoof J; Stinissen P; Somers V
Arthritis Res Ther; 2016 Jun; 18(1):130. PubMed ID: 27267896
[TBL] [Abstract][Full Text] [Related]
34. The role of isotype and epitope specificity of monoclonal antibody mixtures in immunodiffusion reactions.
Griffiths BW; Godard A; Caron JA; Tostowaryk W
Immunology; 1987 Apr; 60(4):491-6. PubMed ID: 2438204
[TBL] [Abstract][Full Text] [Related]
35. Heritability of antibody isotype and subclass responses to Plasmodium falciparum antigens.
Duah NO; Weiss HA; Jepson A; Tetteh KK; Whittle HC; Conway DJ
PLoS One; 2009 Oct; 4(10):e7381. PubMed ID: 19812685
[TBL] [Abstract][Full Text] [Related]
36. Developability assessment for monoclonal antibody drug candidates: a case study.
Garripelli VK; Wu Z; Gupta S
Pharm Dev Technol; 2021 Jan; 26(1):11-20. PubMed ID: 32986499
[TBL] [Abstract][Full Text] [Related]
37. Porcine Ig isotypes: function and molecular characteristics.
Crawley A; Wilkie BN
Vaccine; 2003 Jun; 21(21-22):2911-22. PubMed ID: 12798635
[TBL] [Abstract][Full Text] [Related]
38. Influence of immunoglobulin isotype on therapeutic antibody function.
Beers SA; Glennie MJ; White AL
Blood; 2016 Mar; 127(9):1097-101. PubMed ID: 26764357
[TBL] [Abstract][Full Text] [Related]
39. Sin nombre virus (SNV) Ig isotype antibody response during acute and convalescent phases of hantavirus pulmonary syndrome.
Bostik P; Winter J; Ksiazek TG; Rollin PE; Villinger F; Zaki SR; Peters CJ; Ansari AA
Emerg Infect Dis; 2000; 6(2):184-7. PubMed ID: 10756154
[TBL] [Abstract][Full Text] [Related]
40. Influence of pH on heat-induced aggregation and degradation of therapeutic monoclonal antibodies.
Ishikawa T; Ito T; Endo R; Nakagawa K; Sawa E; Wakamatsu K
Biol Pharm Bull; 2010; 33(8):1413-7. PubMed ID: 20686240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
